272 related articles for article (PubMed ID: 30271504)
1. The Significance of Liquid Biopsy in Pancreatic Cancer.
Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
J Cancer; 2018; 9(18):3417-3426. PubMed ID: 30271504
[TBL] [Abstract][Full Text] [Related]
2. Application of liquid biopsy for surgical management of pancreatic cancer.
Nagai M; Sho M; Akahori T; Nakagawa K; Nakamura K
Ann Gastroenterol Surg; 2020 May; 4(3):216-223. PubMed ID: 32490335
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer.
Watanabe F; Suzuki K; Noda H; Rikiyama T
World J Gastroenterol; 2022 Dec; 28(46):6478-6496. PubMed ID: 36569270
[TBL] [Abstract][Full Text] [Related]
4. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
5. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
6. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.
Chen K; Wang Q; Kornmann M; Tian X; Yang Y
Front Oncol; 2021; 11():644358. PubMed ID: 33718244
[TBL] [Abstract][Full Text] [Related]
7. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
8. Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma.
McGowan R; Sally Á; McCabe A; Moran BM; Finn K
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454933
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need.
Liou GY; Byrd CJ
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173913
[TBL] [Abstract][Full Text] [Related]
10. Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma.
Reese M; Flammang I; Yang Z; Dhayat SA
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941049
[TBL] [Abstract][Full Text] [Related]
11. Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
Heredia-Soto V; Rodríguez-Salas N; Feliu J
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33924143
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
13. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
[No Abstract] [Full Text] [Related]
14. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.
Osei-Bordom DC; Sachdeva G; Christou N
Front Med (Lausanne); 2021; 8():788869. PubMed ID: 35096878
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in pancreatic adenocarcinoma: current perspectives.
Swords DS; Firpo MA; Scaife CL; Mulvihill SJ
Onco Targets Ther; 2016; 9():7459-7467. PubMed ID: 28003762
[TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma.
Buscail E; Maulat C; Muscari F; Chiche L; Cordelier P; Dabernat S; Alix-Panabières C; Buscail L
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31248203
[TBL] [Abstract][Full Text] [Related]
18. [Early stage pancreatic cancer].
Kahlert C; Distler M; Aust D; Gieldon L; Weitz J; Welsch T
Chirurg; 2018 Apr; 89(4):257-265. PubMed ID: 29264630
[TBL] [Abstract][Full Text] [Related]
19. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer.
Khomiak A; Brunner M; Kordes M; Lindblad S; Miksch RC; Öhlund D; Regel I
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33147766
[TBL] [Abstract][Full Text] [Related]
20. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
Mellby LD; Nyberg AP; Johansen JS; Wingren C; Nordestgaard BG; Bojesen SE; Mitchell BL; Sheppard BC; Sears RC; Borrebaeck CAK
J Clin Oncol; 2018 Oct; 36(28):2887-2894. PubMed ID: 30106639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
